You are here

Temasek launches up to US$25m selldown in Shanghai Pharma: IFR

TemasekHoldings140415.jpg
Singapore state investor Temasek Holdings on Tuesday launched a selldown of up to US$25 million in Shanghai Pharmaceuticals, IFR reported, citing a term sheet of the transaction.

[HONG KONG] Singapore state investor Temasek Holdings on Tuesday launched a selldown of up to US$25 million in Shanghai Pharmaceuticals, IFR reported, citing a term sheet of the transaction.

Temasek is offering 8 million shares of Shanghai Pharmaceuticals in an indicative range of HK$23.55 to HK$24.30 each, equivalent to a discount of up to 3 per cent to Tuesday's close, added IFR, a Thomson Reuters publication.

Goldman Sachs was hired as sole bookrunner of the selldown, the terms showed.

REUTERS

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes